Skip to main content
. 2020 Apr 28;15(4):e0232095. doi: 10.1371/journal.pone.0232095

Table 3. Types of adverse drug events.

Organ /System ADE Total ADEs Preventable ADEs
n % n %
Metabolism and nutrition Hypokalemia 4 1.35% 2 8.00%
Hyperkalemia 2 0.68% 2 8.00%
Hypoglycemia 4 1.35% 2 8.00%
Liver and biliary system Hepatotoxicity/ Transaminase disorder 25 8.45% 0 0.00%
Urinary system Nephrotoxicity/ Creatinine disorder 3 1.01% 1 4.00%
Urinary Retention 1 0.34% 0 0.00%
Infectious Candidiasis 2 0.68% 1 4.00%
Infection of the upper respiratory tract 1 0.34% 0 0.00%
Musculoskeletal Myalgia 1 0.34% 0 0.00%
Immune system Allergy 19 6.42% 1 4.00%
Constitutional symptoms Fever 10 3.38% 0 0.00%
Weakness 5 1.69% 0 0.00%
Pain 1 0.34% 0 0.00%
Cold sweating 1 0.34% 0 0.00%
Central and peripheral nervous system Dizziness 4 1.35 0 0.00%
Sleepiness 2 0.68% 0 0.00%
Tremor 1 0.34% 0 0.00%
Gastrointestinal Constipation 9 3.04% 0 0.00%
Diarrhea 22 7.43% 9 36%
Nausea 64 21.62% 0 0.00%
Anorexia 10 3.38% 0 0.00%
Vomiting 22 7.43% 0 0.00%
Acute gastric mucosal Injury 1 0.34% 1 4.00%
Abdominal distension 1 0.34% 0 0.00%
Cardiovascular Hypotension 6 2.03% 1 4.00%
Palpitation 2 0.68% 0 0.00%
Bradycardia 1 0.34% 0 0.00%
Vascular headache 1 0.34% 0 0.00%
Hematologic Hemorrhage 21 7.09% 5 20%
Leukopenia 36 12.16% 0 0.00%
Thrombocytopenia 13 4.39% 0 0.00%
Hemoglobin decline 1 0.34% 0 0.00%
Total 296 100.00% 25 100%